Attorneys general for most US states are bringing a large federal antitrust lawsuit against nearly 20 generic-drug makers, alleging they illegally collaborated to jack up drug prices. Business Insider is the first to report on the unredacted suit, which alleges frequent, close communications among employees of rival companies about how to increase prices. Common drugs had their prices doubled, tripled, or even increased by 1,000% or more, costing taxpayers and patients and violating federal...

Comment

Become a member to take advantage of more features, like commenting and voting.

Jobs to Watch